Study on Current Trends in the Development of Traditional Chinese Medicine in Australia and Policy Proposals of Internationalization of Traditional Chinese Medicine Education in Future

With the rapid rise of China’s economy and the deployment of the Belt and Road Initiative,traditional Chinese medicine(TCM),one of the main components of Chinese culture,has become an important aspect of foreign exchange.Therefore,recent research has focused on how to effectively spread TCM culture internationally and improve TCM acceptance.Australia is currently a representative region with decent TCM development.Taking TCM development in Australia as a starting point,this article analyzes the challenges in TCM development,discusses countermeasures to address these issues,and provides recommendations for improving the international development and dissemination of TCM.

The Internationalization of Traditional Chinese Medicine into the Western World

This paper introduces the internationalization of traditional Chinese medicine into the western world.Internationalization of traditional Chinese medicine(TCM)into the Western world is not a simple or easy task.Its exposure and exportation into the rest of the world should be a task taken on with a special focus and determination on staying strong along the way.Keeping the truth,strength,and integrity in TCM medicine as it is exported is the highest priority and the best way to promote it.Doing this will give it a solid foundation in its new land and for its new patients.Let’s study and analyze what really is required to help TCM avoid all problems and hardships of this exportation process as TCM goes west.

Integrating traditional Chinese (herbal) medicines into risk based regulation-With focus on non-clinical requirements to demonstrate safety

Within the public health sector of Hong Kong(China),there is a consensus around the important role of traditional Chinese medicines.For Hong Kong(China)to play a bridging role to bring Chinese medicines to the global market requires a concerted effort from the government,academic institutes and industries.The release of the final version of the European Medicines Agencies guidance document,which details the acceptance of minimum requirements to nonclinical package in bibliographical applications,grants the opportunity for well-established and traditional herbal medicines to demonstrate an‘acceptable safe’status for registration in the European Union.It is anticipated that this minimum nonclinical package can be applied to demonstrate the safe use of many traditional Chinese medicines regardless of their eligibility to be registered under the simplified procedure within the European Union.This paper conceptualizes an integration of a simplified evaluation route for eligible proprietary Chinese medicines(pCm)with long history of use into the existing drug regulatory framework in Hong Kong(China).Such integration utilizing the minimum nonclinical package,based on bibliographical data or expert report,as proof of evidence to demonstrate safety for pCm with long history of use requires less demand in scientific resources.With Hong Kong(China)conducting‘first hand’review for eligible pCm,it provides an option for overseas and local pharmaceutical companies to register their products in Hong Kong(China)without the need to rely on issuance of Certificate of Pharmaceutical Product from other countries.This could bring eligible pCm with long history of use to reach international risk-based standard and to be marketed globally as‘medicines’to reach their full therapeutic potential.An important process to positioning Hong Kong(China)to compete with other countries in promoting importation and exportation of pCm to better serve the global health.

Promotion of Standardization and Internalization of Traditional Chinese Medicine:Interpretation of Chapters in the 13^(th) Five-Year Special Project for Scientific Innovation of Traditional Chinese Medicine

Traditional Chinese medicine(TCM) contains profound scientific connotation and has great potential in guiding the future development of bioscience,thus becoming the Chinese Treasure of Ancient Science and the Key to Open the Treasury of Chinese Civilization. 13^(th) Five-Year Special Project for Scientific Innovation of Traditional Chinese Medicine has proposed to promote the standardization and internalization of TCM,including implementation of TCM standardized action,establishment of TCM standard system to complete system and adapt development requirements,establishment of a standard system for TCM that can complete system and meets the requirement of development to capture the advantages in international standardization competition,so as to seize the leadership and discourse power in the establishment of TCM international standardization;to promote the implementing great scientific TCM plan to accelerate the international registration of brand-name and high-quality TCM,expedite TCM service and products entering into international main markets of medicines and heath care,propel the scientific cooperation and application of TCM in various countries along One Belt and One Road(B & R),and create Chinese standards and brands,so as to promote the TCM moving towards the whole world.

Discussion on the Chinese Materia Medica Under EU Regulations for Traditional Herbal Medicines

Traditional Chinese medicine(TCM)is a valuable resource for the Chinese nation.With its rich theoretical foundation and long-term practical experience,it provides a solid foundation and rich source for various types of pharmaceutical innovation.The European Union(EU)established Committee on Herbal Medicinal Products(HMPC)and issued 2004/24/EC Directive and 2001/83/EC Directive,which provides legal protection for strengthening the management of traditional medicines and unifying the drug registration standards of member states.It also provides the possibility for Chinese herbal medicine,a precious medical resource,to enter the European market and benefit European citizens.However,in the application process by Chinese traditional medicine manufacturers,there are practical problems such as unclear mechanism of action and differences in drug quality requirements between China and EU.By selecting an appropriate application direction and strategy,the type of drug applied is inclined to the direction of simpler drugs with a simpler mechanism of action.Meanwhile,the policy advantages of local drug manufacturers should be fully taken to strengthen bilateral or multilateral cooperation and other ways to deal with it,providing the possibility to promote the traditional Chinese herbal medicine to go abroad,better serve the people of all countries,and promote the international development of TCM.

基于国际化卓越人才培养的中医内科学双语教学探索与实践

中医内科学蕴含着丰富的原创中医思维和独特诊疗思路,对中医学术的传承发展和推广应用具有基础性的关键作用。双语教学是指以两种语言作为教学媒介,达到学习学科知识和打破语言障碍的双重目的。以培养国际化卓越人才为目标,在高等中医药院校开展中英文双语的中医内科学教学,可以使学生提高中医药专业英语的表达与运用能力,拓展其临床与学术的交流领域,获得更大的发展潜力。文章提出开展中医内科学双语教学能提高中医药学国际认可度、加强中西医学交流合作、传播中华民族特色文化、吸引国外人才来华访问学习。通过探索与实践中医内科学双语教学,努力达到创新教学理念、改革教学方法、开展形成性评价等,有利于提升高等中医药院校中医学专业国际化教学水平与学术影响力。

高质量发展视域下中医药院校教师国际化培养模式研究

教师是人才培养的关键所在,是高等教育质量的有力保障。中医药院校教师在国际化建设中面临的问题和挑战主要有:学校顶层设计缺乏、学科间国际化发展不均衡、教师国际化意识不足。面对这些挑战,中医药院校需要建立学校-部门-教师三级联动的“点、线、面”教师国际化培养模式,通过加强顶层设计,完善培养体系,夯实政策保障,扩大国际交流,引进海外人才带动本土教师发展,提升教师国际化意识和跨文化能力,多元协同培养,加快教师队伍的国际化进程,从而推进中医药高等教育高质量发展。

在地国际化临床医学人才培养实施路径

党的十九届五中全会提出,要加快构建以国内大循环为主体、国内国际双循环相互促进的新发展格局。以国内大循环为主体双循环战略的提出,对新时代国际化复合型医学精英人才培养提出新要求。重庆医科大学以中外合作办学为契机,以培养具有国际视野的复合创新型临床医学精英人才为目标,以临床岗位胜任力为导向,以学生发展为中心,充分利用国际国内资源,通过培养体系、管理体制、教学资源、师资队伍、评价体系、多元文化等“六大融合”,构建以“一体两翼”课程体系、增强虚拟混合学习模式、数字化资源赋能为主要特征的在地国际化临床医学人才培养模式,开启“以我为主”的临床医学人才培养在地国际化高质量发展新格局,在国内自主培养具有家国情怀、国际视野的创新型未来卓越医学人才。

基于SWOT分析的中医援外医疗队海外推广中医药策略研究——以中国援柬埔寨中医抗疫医疗队为例

中医药是我国独特的卫生资源、经济资源和科技资源,近年来中医药国际传播范围逐步扩大,影响力不断提升,首支中国援外中医医疗队派出为中医药海外推广提供了新路径。本文应用SWOT法,分析得出中医援外医疗队海外推广中医药具有推广力度强、范围广、程度深、效果佳的优势,存在派出与管理机制尚不健全、组建与海外工作难度高、中医器材、药品运输、出口挑战大的劣势。在国家层面高度重视中医药“走出去”、中医药国际认可度提高海外需求提高、全球疫情形势发生转变的机遇下,还需应对文化障碍、法律障碍、全球传统医学替代性竞争加剧的挑战。在中医援外医疗队海外推广中医药方面提出尽快形成中医援外医疗队常态化建制、高位推动形成中医药海外推广合力、优化中医药出口环境、加强海内外人才培养的建议。

“一带一路”背景下留学生家属朋友的中医药认知及应用的调查研究

目的 中医药为中华民族的健康繁衍贡献了巨大的力量,但在国际社会中的认知度和接受度仍有待提高。本研究的目的是调查山西中医药大学具有中医药学习经历的留学生的家属朋友的中医药认知及应用度。方法 以学习过中医药课程的留学生的家属朋友为研究对象。自行设计问卷,通过问卷星网站收集数据。结果 87.9%(87/99)的留学生家属朋友认同中医药对疾病的防治作用,并乐意接受中医药的预防保健知识。超过50%的留学生家属朋友在日常生活中应用中医非药物保健方法。约80%的留学生家属朋友通过家庭成员、朋友和医生了解中医药知识。结论 大多数留学生家属朋友认同中医,但对中医的诊疗方法尤其是汤药的认识和理解有待提高。建议提高留学生的中医药基础教育,使其成为中医药的崇拜者和实施者,进而增强其中医药使者的作用,加快中医药国际化的进程。

中医药对外传播视域下大学英语口语课程模式研究

在中医药对外传播的背景下,此研究基于中国特色的产出导向法(POA),探讨了中医药院校大学英语口语递进式课程体系的构建与实施。以“驱动-促成-评价”为课堂实践流程,从初阶英语口语课到进阶英语演讲课程,让学生以中华传统文化及中医药文化为内容基石,用英语讲中国故事,推广中医药,在提高学生英语口语能力的同时,培养学生中外文化互鉴交流的能力和对外传播中医药的跨文化能力。

THE MODERNIZATION AND INTERNATIONALIZATION OF TRADITIONAL MEDICINE, CHALLENGES AND OPPORTUNITIES

Traditional Chinese medicine(TCM)is the main body of natural medicine in China,and TCM prescriptions are the main application forming TCM.For thousands of years,Chinese people have learned to use multiple herbal medicines in proper proportions for therapeutic use,in order to overcome the side effect of some herbs,as well as to bring synergy effects.From individual herbal

阿育吠陀国际化、标准化现状及与中医药的比较

阿育吠陀是印度有代表性的传统医学,近年其国际化及标准化发展迅速,与中医药学的交集日益增多,但是国内相关研究很少。通过分析印度政府、世界卫生组织(WHO)和国际标准化组织(ISO)相关文件,从与WHO合作、被其他国家认可、政府间国际平台推广及国际研究教育合作方面分析阿育吠陀在国际社会的推广应用情况,并从标准发布机构入手分析其国内标准化情况,同时与中医药在WHO和ISO国际标准化情况进行比较,为中医药学的相关领域发展提供参考与借鉴。

中医药国际科技创新交流与合作的障碍与路径研究

基于中医药科技创新的内涵与特征,分析中医药科技创新对中医药国际交流的作用及意义,梳理出当前中医药国际科技创新交流合作存在文化阻隔的认知障碍、标准缺失的准入障碍和机制失范的质量障碍,它们影响了中医药国际交流合作的质量与效率。提出通过打造文化矩阵、强化标准建设、建立协调机制以助力中医药国际科技创新交流,拓宽中医药国际科技创新合作渠道等针对性策略,为中医药国际交流合作提供稳定的内生动力。

“一带一路”国家中医药差异化发展策略研究

“一带一路”倡议提出后,中国与“一带一路”国家的经贸往来日益密切。作为“一带一路”倡议的重要组成部分,中医药为保障和促进人类健康发挥着重要作用。“一带一路”倡议为推进中医药境外发展提供了重大历史机遇。根据“一带一路”国家中医药发展环境特征,通过具体分析其在经济与市场、人口、政治与法制、文化与教育、医疗卫生、基础设施以及自然地理七个维度的发展情况,将“一带一路”沿线的35个主要国家划分为重点推进型、强化合作型、特色发展型和积极突破型,并针对不同类型的国家提出中医药差异化发展策略。重点推进型国家要加大推进力度,强化中医药强势品牌;强化合作型国家要深化国际合作,加快中医药发展传播;特色发展型要强化政府间合作,优选项目重点支持;积极突破型国家要加强中医药文化交流,适当控制投资风险。为政府相关部门制定中医药国际化战略以及相关企业、机构中医药境外发展提供参考。

人参品种术语标准化若干重点问题的探讨

人参为我国贵细大品种中药材之一,药用历史悠久,在国内外享有较高知名度。因生长环境和加工方式的不同,市场上流通的人参品种繁多且价格悬殊。但目前市场流通的人参品种存在分类边界不清晰、不同品种定义模糊、相应术语的英文翻译不准确和不一致等问题,导致以次充好和正伪品混杂现象层出不穷,无法真正保障人参质量,无法规范人参贸易市场、促进优质优价,也影响了人参药材及相关产品的国际化贸易和发展。因此,目前亟需统一名词术语标准,对不同品种人参加以科学区分和规范。梳理了人参品种术语标准研究现状及问题,基于相关理论和实际问题提出人参品种术语分类、定义及英文翻译的主要原则,开展实例分析研究,并对人参术语标准化工作提出相关建议。

外语课程思政教学与国际化人才培养路径研究

中医药是我国传统文化的瑰宝,中医院校作为传承中华传统文化的重要基地,承担着培养国际化医学人才、推动中华文化走向世界的重要任务。此研究以新文科背景为切入点,分析大学外语思政教育与中医药国际化人才培养的现状与逻辑关联,探索大学外语思政教学改革,构建“外语+中医”复合型国际中医人才培养的模式,为大学外语思政教育与国际化人才培养提供有益经验与支持。

加拿大天然健康产品质量、监管要求及胆宁片注册、认证、出口实践

加拿大作为药品监管水平和国际影响力较高的国家,已明确承认中成药的药品身份。中成药在加拿大申请产品许可证,需要提交产品的安全性、有效性和高质量的支持性证据。本文通过介绍加拿大天然健康产品的质量、监管要求,为中成药在加拿大注册、认证和上市应用提供参考;同时介绍胆宁片在加拿大成功注册、认证和出口实践,为中药国际化提供借鉴和启示。

以标准化推动中医药国际化的相关问题

推进中医药现代化是中医药事业发展的战略选择,中医药国际化是中医药现代化的主要内容之一,而标准化战略是实现中医药现代化、国际化的三大战略之一。本文论述了如何整合各方面的力量,做好宏观规划,全面推进中医药标准化建设,并以标准化推动中医药国际化的相关问题。

2006年美国MEDLINE收录生殖医学期刊一览表及情况分析

美国国立医学图书馆(NLM)建立的MEDLINE数据库是医学科技人员最常用的生物医学文献检索系统,所收录的文献基本代表了当今医学领域的最高水平。NLM公布的2006年版MEDLINE收录期刊目录共收录4 959种期刊,其中生殖医学期刊46种,主要包括男科学、生育与不孕等内容。生殖医学工作者应熟悉MEDLINE收录的生殖医学期刊,关注其刊载的学科前沿问题,并重视应用英语撰写论文向其投稿。而就生殖医学期刊工作者而言,应通过创办英文版期刊等措施,提高期刊国际化程度,争取早日进入MEDLINE、《科学引文索引》(SC I)等国际著名检索系统。本文主要介绍了MEDLINE收录的生殖医学期刊(2006年版)并就其收录情况作了简要分析,有助于指导生殖医学、男科学等相关学科研究人员投稿、查阅文献及订阅国际生殖医学期刊,同时也有利于国内生殖医学期刊工作者了解MEDLINE收录的生殖医学期刊并向其学习。